Neurologists Interested in Cell Therapy in Neuro-Immune Diseases, but Safety and Logistics Will Shape Adoption, According to Spherix Global Insights
VictoriaPark AI 编辑部·1 sources
Sources
- Business Insider — Neurologists Interested in Cell Therapy in Neuro-Immune Diseases, but Safety and Logistics Will Shape Adoption, According to Spherix Global Insights
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。